Core Viewpoint - Bayer has received approval from the U.S. Food and Drug Administration for its drug aimed at providing relief for menopause symptoms [1] Group 1 - The FDA approval marks a significant milestone for Bayer in the women's health sector [1] - This drug is expected to address a critical need for menopause relief among women [1] - The approval may enhance Bayer's market position and drive revenue growth in the healthcare segment [1]